Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Metsera Inc. (MTSR:NASDAQ), powered by AI.
Metsera Inc. is currently trading at $70.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Metsera Inc. on Alpha Lenz.
Metsera Inc.'s P/E ratio is -34.7.
“Metsera Inc. trades at a P/E of -34.7 (undervalued) with modest ROE of -108.4%.”
Ask for details →Metsera Inc. is a prominent player in the technology and communication sector, providing cutting-edge solutions and services to diverse markets around the globe. The company specializes in developing high-performance telecommunications equipment and software, facilitating enhanced connectivity and communication capabilities. Focusing on both urban and rural markets, Metsera Inc. aims to bridge the digital divide through innovative networking solutions that bolster internet accessibility and reliability. The company is deeply involved in the creation of 5G network infrastructures and IoT (Internet of Things) technologies, playing a pivotal role in advancing smart city projects and industrial automation. Metsera's product offerings cater to a wide range of clients, including internet service providers, mobile network operators, and large enterprises seeking to upgrade their communication systems. With its headquarters in a tech-driven economic hub, Metsera Inc. actively contributes to the evolving landscape of global telecommunications. Its commitment to research and development ensures that it remains at the forefront of technological advancements, impacting industries such as healthcare, transportation, and agriculture by enhancing connectivity and driving the integration of digital solutions.
“Metsera Inc. trades at a P/E of -34.7 (undervalued) with modest ROE of -108.4%.”
Ask for details →Metsera Inc. (ticker: MTSR) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 104 employees. Market cap is $7.3B.
The current price is $70.5 with a P/E ratio of -34.73x and P/B of 25.28x.
ROE is -108.40%.